HARMONY ALERT: Bragar Eagel & Squire, P.C. is Investigating Harmony Bi...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 6, 2023

S CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against SentinelOne, Inc. • Lost Money in Tingo Group, Inc.? • WCM Champions of Change Close the Market • ExThera Medical Exhibits at the 2023 International Conference on Extracorporeal Organ Support in Zagreb, Croatia • With New Recycling Center Fully Operational, EGGER Now Manufactures Products With Post-Consumer Recycled Wood • TEXAS CHILDREN'S HOSPITAL'S DR. MARIA ELENA BOTTAZZI AWARDED THE VILCEK-GOLD AWARD FOR HUMANISM IN HEALTHCARE • ReNew Announces Results for the Fourth Quarter (Q4 FY23) and Fiscal 2023, both ended March 31, 2023 • Legend Biotech Announces Submission of Supplemental Application to the U.S. FDA for Expanded Use of CARVYKTI® (ciltacabtagen • PrideStaff Financial Named to ClearlyRated's Best Staffing Firms for Women List • PrideStaff Named to ClearlyRated's Best Staffing Firms for Women List • PRIMO Partners Honored with Distinguished 2023 MVP Award from Multi-Unit Franchisee Magazine • University of Phoenix Collaborates with Ardent Health Services to Provide Education and Tuition Reimbursement for Employees • Roth Staffing Named to ClearlyRated's Inaugural Best Staffing Firms for Women List • Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • ACC Honors Companies for Efforts to Advance Sustainability with its 2023 Sustainability Leadership Awards • Maine Public Utilities Commission Unanimously Approve Central Maine Power Multi-year Rate Plan • Morgan Stanley Global M&A Chair Robert Kindler to Join Paul, Weiss • AVOCADO TO DONATE 1% OF REVENUE TO WOMEN'S EARTH ALLIANCE • Common Future Launches New Women-led, Multiracial Co-CEO Model • Antibiotic Overuse a Slippery Slope for STI Prevention, says AHF

HARMONY ALERT: Bragar Eagel & Squire, P.C. is Investigating Harmony Biosciences Holdings, Inc. on Behalf of Harmony Stockhol

NEW YORK , March 30 /Businesswire/ - Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (NASDAQ: HRMY) on behalf of Harmony stockholders. Our investigation concerns whether Harmony has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On March 28, 2023, Scorpion Capital ("Scorpion") published a short report on Harmony, which Scorpion described as "[o]ne of the most thoroughly corrupt healthcare schemes in recent years, deserving of criminal and political scrutiny". Scorpion described "Harmony's drug Wakix (pitolisant) [as] a repeat of the Seldane (terfenadine) saga, another histamine antagonist that the FDA pulled from the market and which is the poster child for cardiac toxicity via fatal QT prolongation/arrhythmia." Scorpion asserted that it "obtained dozens of serious adverse event reports from the FDA via Freedom of Information Act requests filed over several months, and they paint a devastating picture of the drug's risk to even young, otherwise healthy patients, including a recent sudden cardiac death, 2 weeks after starting Wakix on the day it was titrated to the highest dose."

On this news, Harmony's stock price fell sharply during intraday trading on March 28, 2023.

If you purchased or otherwise acquired Harmony shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.